Literature DB >> 99475

Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites.

J P Verhave, G T Strickland, H A Jaffe, A Ahmed.   

Abstract

In an effort to understand the mechanisms involved in the protective immunity to malarial sporozoites, an A/J mouse/Plasmodium berghei model was studied. Protective immunity could consistently be adoptively transferred only by using sublethal irradiation of recipients (500 R); a spleen equivalent (100 X 10(6))of donor cells from immune syngeneic mice; and a small booster immunization (1 X 10(4)) of recipients with irradiation-attenuated sporozoites. Recipient animals treated in this manner were protected from lethal challenge with 1 X 10(4) nonattenuated sporozoites. Immune and nonimmune serum and spleen cells from nonimmune animals did not protect recipient mice. Fewer immune spleen cells (50 X 10(6)) protected some recipients. In vitro treatment of immune spleen cells with anti-theta sera and complement abolished their ability to transfer protection. This preliminary study suggests that protective sporozoite immunity can be transferred with cells, and that it is T cell dependent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99475

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Anti-sporozoite antibodies.

Authors:  M R Hollingdale
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.

Authors:  M F Good; D Pombo; I A Quakyi; E M Riley; R A Houghten; A Menon; D W Alling; J A Berzofsky; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.

Authors:  M Sedegah; R L Beaudoin; W R Majarian; M D Cochran; C H Chiang; J Sadoff; A Aggarwal; Y Charoenvit; S L Hoffman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

5.  Delayed-type hypersensitivity and protection in mice following immunization with Plasmodium berghei sporozoites.

Authors:  J P Verhave; G T Strickland
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites.

Authors:  Alejandro Jordán-Villegas; Anilza Bonelo Perdomo; Judith E Epstein; Jesús López; Alejandro Castellanos; María R Manzano; Miguel A Hernández; Liliana Soto; Fabián Méndez; Thomas L Richie; Stephen L Hoffman; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

7.  Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.

Authors:  A R Lussow; G Del Giudice; L Rénia; D Mazier; J P Verhave; A S Verdini; A Pessi; J A Louis; P H Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 8.  Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.

Authors:  Michael Glen Overstreet; Ian Andrew Cockburn; Yun-Chi Chen; Fidel Zavala
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 9.  Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes.

Authors:  Janna Heide; Kerrie C Vaughan; Alessandro Sette; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.